Response and non-response to renal denervation: Who is the ideal candidate?

EuroIntervention

Volumn 9, Issue , 2013, Pages R54-R57

  Ukena, Christian ^a   Cremers, Bodo ^a   Ewen, Sebastian ^a   Böhm, Michael ^a   Mahfoud, Felix ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Non response; Patient selection; Procedural parameters; Sympathetic activation

Indexed keywords

BLOOD PRESSURE REGULATION; EVIDENCE BASED PRACTICE; GENERAL CONDITION; HEALTH STATUS; HUMAN; HYPERTENSION; INAPPROPRIATE PRESCRIBING; KIDNEY DENERVATION; MAINTENANCE THERAPY; PATIENT SELECTION; PREDICTOR VARIABLE; PREVALENCE; REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE; TREATMENT RESPONSE; ADRENERGIC SYSTEM; BLOOD PRESSURE; CATHETER ABLATION; DRUG EFFECT; DRUG RESISTANCE; INNERVATION; KIDNEY; MEDICATION COMPLIANCE; METHODOLOGY; PATHOPHYSIOLOGY; SYMPATHECTOMY; DRUG EFFECTS;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATHETER ABLATION; DRUG RESISTANCE; HUMANS; HYPERTENSION; KIDNEY; MEDICATION ADHERENCE; PATIENT SELECTION; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TREATMENT FAILURE;

EID: 84881084985     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV9SRA10     Document Type: Review

References (23)

1. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911-7.
2. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-9.
3. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932-4.
4. Padeletti L, Paoletti Perini A, Gronda E. Cardiac resynchronization therapy: the issue of non-response. Heart Fail Rev. 2012;17:97-105.
5. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-81.
6. Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B, Laufs U, Neuberger HR, Böhm M. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. Int J Cardiol. 2012 [Epub ahead of print].
7. Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA, Symplicity HTN-2 Investigators. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation. 2012;126:2976-82.
8. Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C. ESH position paper: renal denervation-An interventional therapy of resistant hypertension. J Hypertens. 2012;30:837-41.
9. Mahfoud F, Himmel F, Ukena C, Schunkert H, Böhm M, Weil J. Treatment strategies for resistant arterial hypertension. Dtsch Arztebl Int. 2011;108:725-31.
10. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension. 2012;60:419-24.
11. Bland JM, Altman DG. Regression towards the mean. BMJ. 1994;308:1499.
12. Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H. Renal sympathetic denervation as secondline therapy in mild resistant hypertension: a pilot study. Catheter Cardiovasc Interv. 2013;81:335-9.
13. Czernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne AP, Lambers Heerspink HJ, Perkovic V, Huxley R, Arima H, Patel A, Chalmers J, Woodward M, MacMahon S, Neal B, Blood Pressure Lowering Treatment Trialists C. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-Analysis of randomized trials. J Hypertens. 2011;29:4-16.
14. Ewen S, Ukena C, Böhm M, Mahfoud F. Percutaneous renal denervation: new treatment option for resistant hypertension and more Heart. 2013 Mar 6. [Epub ahead of print].
15. Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation. 2011;123:209-15.
16. Brandt MC, Reda S, Mahfoud F, Lenski M, Bohm M, Hoppe UC. Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension. J Am Coll Cardiol. 2012;60:1956-65.
17. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens. 2002;11:197-200.
18. Mahfoud F, Böhm M, Rump LC, Vonend O, Schmieder RE, Kintscher U. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. Hypertension. 2013;61:e17.
19. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011;123:1940-6.
20. Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, Michalowska I, Kabat M, Warchol E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559-65.
21. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, Hoppe UC. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901-9.
22. Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC, Fuchs FD. Health-related quality of life and hypertension: a systematic review and meta-Analysis of observational studies. J Hypertens. 2011;29:179-88.
23. Hering D, Mahfoud F, Walton AS, Krum H, Lambert GW, Lambert EA, Sobotka PA, Böhm M, Cremers B, Esler MD, Schlaich MP. Renal denervation in moderate to severe CKD. J Am Soc Nephrol. 2012;23:1250-7.